Peter Weeke
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Diabetes Treatment and Management, Genetic Associations and Epidemiology, Cardiovascular Function and Risk Factors, Cardiomyopathy and Myosin Studies
Most-Cited Works
- → Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death(2013)542 cited
- → Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials(2024)226 cited
- → Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial(2024)190 cited
- → Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study(2015)106 cited
- → Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies(2016)102 cited
- → SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation(2014)79 cited
- → Exome Sequencing Implicates an Increased Burden of Rare Potassium Channel Variants in the Risk of Drug-Induced Long QT Interval Syndrome(2014)75 cited
- → Whole Exome Sequencing Identifies a Causal RBM20 Mutation in a Large Pedigree With Familial Dilated Cardiomyopathy(2013)71 cited
- → Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart(2015)63 cited
- → A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough(2015)63 cited